Actinium Pharmaceuticals, Inc. To Host Advisory Meeting At The 2014 ASBMT And CIBMTR Conference
2/26/2014 12:23:13 PM
NEW YORK, NY--(Marketwired - Feb 26, 2014) - Actinium Pharmaceuticals, Inc. (OTCBB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, will host an advisory meeting with leading bone marrow transplant experts during the combined annual meetings of the American Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) in Grapevine, Texas on Saturday, March 1, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by